VasQ™ Extravascular Support Achieves Critical TPT Payment Status
![VasQ™ Extravascular Support Achieves Critical TPT Payment Status](https://investorshangout.com/images/blog/ihnews-VasQ%E2%84%A2%20Extravascular%20Support%20Achieves%20Critical%20TPT%20Payment%20Status.jpg)
Revolutionizing Kidney Care with VasQ™ Extravascular Support
Laminate Medical Technologies is making significant strides in kidney care with its innovative VasQ™ extravascular support device. Recently, the U.S. Centers for Medicare & Medicaid Services (CMS) announced that VasQ would receive a Transitional Pass-Through (TPT) payment, a strategic development for both patients and healthcare providers.
Understanding the Transitional Pass-Through Payment
The TPT payment, introduced under billing code C8000, allows additional Medicare reimbursement for healthcare providers who utilize the VasQ device during the arteriovenous fistula creation process. This decision marks an important innovation within the dialysis sector, enabling immediate patient access to advanced devices. Like many products vying for a spot in the healthcare marketplace, VasQ experienced rigorous examination and support through the FDA Breakthrough Devices designation, reinforcing the necessity for innovative solutions in patient care.
The Role of Patient Advocacy
A notable aspect of VasQ's journey to receiving TPT payment is the robust advocacy from patients and organizations like the American Association of Kidney Patients (AAKP). Since 2021, AAKP has actively worked with Laminate Medical, raising awareness of the urgent need for innovations that enhance dialysis patient care. Their tireless advocacy played a crucial role in garnering support, demonstrating how patient voices can influence important healthcare decisions.
Benefits of the VasQ Device for Patients
With a strong commitment to improving patient outcomes, VasQ aims to significantly increase the success rate of arteriovenous fistulas. Studies have consistently demonstrated that VasQ can enhance results without necessitating additional surgical interventions. Moreover, this innovative technology provides hope for patients regarding safer removal of central venous catheters (CVCs), thereby lowering the risks of hospitalization associated with catheter-related bloodstream infections.
Expert Insights on VasQ's Impact
Edward Hickey, III, president of AAKP, articulated his optimism regarding the future of patient-centered kidney care. He emphasized the significance of aligning FDA regulatory actions with CMS payment decisions, highlighting the need for ongoing communication in the healthcare landscape. The collaboration between patients and regulatory bodies is already starting to yield positive results, evidenced by VasQ's recognition and the support it has received from patients and professionals alike.
Looking Ahead with VasQ
Tammy Gilon, CEO of Laminate Medical Technologies, expressed gratitude for the support received from patients, AAKP, the FDA, and CMS. The recent assignment of the Medicare billing code is a vital milestone in Laminate Medical's mission to elevate the standard of care for hemodialysis patients. With VasQ, the organization is poised to not only offer patients new options but also to alleviate burdens on healthcare providers and drive down overall costs associated with kidney care.
Integrating VasQ into Clinical Practice
The establishment of the TPT payment will facilitate the integration of VasQ into existing vascular access procedures within healthcare facilities. By allowing practitioners to adopt this innovative technology smoothly, more patients can access the potential benefits VasQ offers. The healthcare landscape is evolving, and technologies like VasQ are paving the way for improved practices.
Frequently Asked Questions
What is VasQ™ and its significance in kidney care?
VasQ™ is an extravascular support device designed to enhance the dialysis fistula creation process, aiming to improve patient outcomes and reduce complications.
What does the TPT payment mean for healthcare providers?
The TPT payment allows providers to receive additional reimbursement for using VasQ, which encourages the adoption of innovative dialysis solutions.
How did patient advocacy influence VasQ's journey?
Advocacy from organizations like AAKP helped raise awareness of the need for innovation in kidney care, which contributed to the CMS's decision regarding VasQ.
What are the potential benefits of using VasQ for patients?
Patients using VasQ may experience higher success rates with fistulas, earlier removal of CVCs, and reduced risks associated with infections and complications.
How can healthcare facilities incorporate VasQ into their practices?
The TPT payment simplifies the integration of VasQ into current vascular access procedures, making it more accessible for healthcare providers and their patients.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- ICAIRE's New UNESCO Status: A Milestone for Global AI Ethics
- Liguori Academy Achieves Semifinalist Status in Yass Prize
- Bank of America CEO Praises Buffett’s Support Amid Changes
- RTX Secures $112 Million Contract for F-35 Propulsion Support
- Batteries Plus Prepares for Hurricane Francine with Local Support
- Tunnel to Towers Foundation Supports Families of Fallen Heroes
- Centaurus Financial Achieves Top Ranking as a Broker/Dealer
- Global Bioenergies Achieves Leaner Financial Loss in 2024
- Simpli.fi Achieves Noteworthy Recognition in Ad Tech Landscape
- NS Pharma's Innovative Therapy for Duchenne Gains FDA Support
Recent Articles
- Millstone Medical Enhances Growth Strategy with New Talent
- Protege Secures $10 Million to Transform AI Training Data Access
- Canary Speech Patents Innovative Technology for Voice Analysis
- JPMorgan Strengthens Mid-Cap Division with New Leaders
- Nike Stockholders Reject Proposal to Enhance Worker Rights
- Michael Saylor's Bold Bitcoin Predictions Ignite Community
- Key Factors Driving Bitcoin's Potential Rise to $60,000
- Massive Bitcoin Movement Sparks Interest in the Market
- Exploring the Financial Impact of Celebrity Homeownership
- Understanding the Boom of the Cannabis Edibles Market Leaders
- SiriusXM's Strategic Growth: Embracing Buybacks and Innovation
- Trinity Biotech's Innovative Patent: A Game Changer in CGM Tech
- Understanding Ares Management's Short Selling Landscape
- Park Aerospace Corp. Announces Quarterly Cash Dividend
- Discovering the Long-Term Gains of IDEXX Laboratories Stock
- Understanding Short Interest Trends for Krystal Biotech Stocks
- Shell plc Reports Significant Share Purchase in September
- Regeneron Pharmaceuticals: A Remarkable Investment Journey
- Analyzing Market Sentiment Around TopBuild: What Investors Need to Know
- Apple's Glowtime Event Sparks Mixed Analyst Reactions on iPhone 16
- Analyzing Market Sentiment for Mueller Industries (MLI)
- Analyzing the Surge in Short Interest for Applied DNA Sciences
- Understanding the Implications of Lumentum Holdings' Short Interest
- Brent Oil Faces Pressure Amidst China's Sluggish Growth
- Otis Worldwide Corporation Expands Footprint in Taiwan Market
- Dine Brands Global Launches Exciting Dual-Branded Restaurant
- Community Engagement Thrives at Highland Park Synagogue
- Little Bites® Unveils Exciting Biggie Muffins for Snack Lovers
- Innovative Biotics Solutions for Gut and Mental Health Issues
- AMDA College Shines Brightly on Broadway's Top Colleges List
- Okuma Introduces LB2000 EX III Horizontal Lathe for Precision
- Introducing the Next Generation Okuma LB4000 EX III Lathe
- Audacy's 'I'm Listening' Initiative: A Lifeline for Mental Health
- Impact of Currency Movements on Hedge Fund Performance
- Nippon Steel's Last-Bid Visit to Washington for US Steel Deal
- Barclays Champions Growth Stocks Amidst Market Changes
- Starbucks' New CEO Brian Niccol: Plans To Revolutionize Customer Experience
- Ethernity Chain Launches $10 Million Grant Initiative for Innovators
- Market Insights: Stocks React to Inflation and Debates
- AWS and Oracle Forge New Partnership Amid Changing Landscape
- Exploring the Rise of the Circular Fashion Market to $13.8 Billion
- RFID Chips Market Poised for Growth to USD 23.2 Billion
- Sampo plc Advances with Exchange Offer for Topdanmark Shares
- FirstService Increases Shareholder Value with New Dividend
- Discover Luxury Living at Marlowe Palomar Heights Today
- Investing in Insulet: From $1000 to Over $20,000 in 15 Years
- Investment Journey: The 10-Year Growth of Insmed Shares
- Walmart's Potential Breakout: A Closer Look at the Future
- Investors Alert: Class Action Lawsuit Against WEBTOON Entertainment
- Investors Seek to Lead Class Action Against Extreme Networks